tiprankstipranks
Pharming Group (PHAR)
NASDAQ:PHAR

Compare Pharming Group (PHAR) vs. Competitors

198 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$17.09
$1.22B
440.78
111.25%
3 Buy
0 Hold
0 Sell
Strong Buy
Trevi Therapeutics
$13.47
$1.69B
-42.49
149.81%
7 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$10.15
$1.02B
-5.55
135.50%
10 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$316.14
$8.80B
-21.87
1010.43%
14 Buy
1 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$8.30
$799.34M
-6.70
-39.20%
3 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.43
$619.29M
-2.57
193.16%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
17.09
9.09
113.63%
TRVI
Trevi Therapeutics
13.19
7.24
121.68%
ORIC
Oric Pharmaceuticals
10.15
5.04
98.63%
PRAX
Praxis Precision Medicines
316.14
286.39
962.66%
SPRY
ARS Pharmaceuticals
8.05
-6.42
-44.37%
PRME
Prime Medicine, Inc.
3.43
2.10
157.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts